RxDoctor Payments DataLook up a doctor →

Muwaffaq Salameh, MD

Nephrology · Bay City, MINPI 1851647390

Payments from drug & device makers

$164,451in general payments, 2019–2025

Across 459 payments — averaging $358.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$100K
  • Bayer$22K
  • Otsuka America Pharmaceutical, Inc.$22K
  • Akebia Therapeutics Inc$16K
  • GSK$1K
  • Calliditas Therapeutics US Inc.$533
  • plus $3K from 18 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$164,451 in reported general payments places this provider in the 90th percentile of 325 nephrology providers in Michigan.

See all nephrology providers in Michigan

Medicare billing

Part B allowed, 2024
$433,089
Medicare patients
730
Services billed
4,321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Bay City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →